The World Health Organization’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is more likely to come this month, official sources mentioned Monday.
The WHO has to date accredited Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.
Covaxin is among the six vaccines which have acquired emergency use authorization from India’s drug regulator and is getting used within the nationwide inoculation programme, together with Covishield and Sputnik V.
“The WHO approval for Covaxin is probably going this month,” an official supply mentioned.
The Center had advised Rajya Sabha in July that each one paperwork required for the WHO’s Emergency Use Listing (EUL) have been submitted by Bharat Biotech as of July 9, and the worldwide well being physique had commenced the overview course of.
(Except for the headline, this story has not been edited by NDTV employees and is revealed from a syndicated feed.)